Frontiers in Psychiatry (Jul 2022)

A bibliometrics analysis and visualization of autism spectrum disorder

  • Ping Rong,
  • Ping Rong,
  • Qianfang Fu,
  • Qianfang Fu,
  • Xilian Zhang,
  • Xilian Zhang,
  • Hui Liu,
  • Hui Liu,
  • Shuyi Zhao,
  • Shuyi Zhao,
  • Xinxin Song,
  • Xinxin Song,
  • Puxing Gao,
  • Puxing Gao,
  • Rong Ma,
  • Rong Ma

DOI
https://doi.org/10.3389/fpsyt.2022.884600
Journal volume & issue
Vol. 13

Abstract

Read online

BackgroundThe prevalence of autism spectrum disorder (ASD) increased rapidly in the last 20 years. Although related research has developed rapidly, little is known about its etiology, diagnostic marker, or drug treatment, which forces researchers to review and summarize its development process and look for the future development direction.MethodsWe used bibliometrics to analyze papers of ASD in the Web of Science from 1998 to 2021, to draw the network of authors, institutions, countries, and keywords in the ASD field, and visualize the results.ResultsA total of 40,597 papers were included with a continually increasing trend. It turns out that the research on ASD is mainly concentrated in universities. The United States has the largest number of ASD studies, followed by England and Canada. The quality of papers related to ASD is generally high, which shows that ASD research has become a hot spot of scientific research. The keywords of ASD etiology and diagnostic markers can be classified into at least 7 aspects. The detection of keywords shows that ASD research is mostly based on its subtypes, takes children as the study population, focuses on neurodevelopmental imaging or genetics, and pays attention to individual differences. And ASD research has changed greatly under the impact of Corona Virus Disease 2019 in the past 2 years.ConclusionWe consider the future development direction should be based on the improvement of case identification, accurate clinical phenotype, large-scale cohort study, the discovery of ASD etiology and diagnostic markers, drug randomized controlled trials, and telehealth.

Keywords